Zymeworks ZYME Adjustment for dilutive effect of liability classified stock options (in shares)
Adjustment for dilutive effect of liability classified stock options (in shares) at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept zyme:IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsLiabilityClassified.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's adjustment for dilutive effect of liability classified stock options (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zymeworks's adjustment for dilutive effect of liability classified stock options (in shares)?
- Zymeworks (ZYME) reported adjustment for dilutive effect of liability classified stock options (in shares) of 26K in Q1 2026.
- How has Zymeworks's adjustment for dilutive effect of liability classified stock options (in shares) changed year-over-year?
- Zymeworks's adjustment for dilutive effect of liability classified stock options (in shares) decreased by 53.1% year-over-year, from 55.4K to 26K.
- What does adjustment for dilutive effect of liability classified stock options (in shares) mean?
- Quantifies the number of additional common shares that would be issued if all liability-classified stock options were exercised or converted. This metric is essential for calculating fully diluted earnings per share and understanding potential shareholder dilution. It provides transparency into the total equity overhang from employee and stakeholder compensation plans.